Unihealth Hospitals
Key Fundamentals
SMEHealthcare ServicesHealthcarePrice-based figures as of · TTM
- ROCE
- 24.50%
- Debt to Equity
- 0.24
- EPS (TTM)
- —
- Book Value
- ₹87.50
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- 6.22
- ROE
- 21.50%
- Dividend Yield
- 0.00%
- EBITDA
- ₹58.80 Cr
- 52W High
- ₹820.00
- 52W Low
- ₹153.55
- Volume
- 0
Peer Comparison
Healthcare › Healthcare Services › Hospitals › Hospital
| ₹8,599.50 | 59.18 | ₹1,22,850 Cr | 13.04 | 0.24% | 21.20% | 17.40% | ₹26,430 Cr | ₹2,171 Cr | |
| ₹927.15 | 61.89 | ₹89,301 Cr | 7.96 | 0.22% | 14.70% | 14.70% | ₹8,712 Cr | ₹1,457 Cr | |
| ₹667.20 | 88.96 | ₹86,479 Cr | 5.34 | 0.00% | 6.64% | 8.30% | ₹11,400 Cr | ₹906 Cr | |
| ₹719.55 | 117.00 | ₹59,927 Cr | 14.91 | 0.44% | 11.30% | 11.60% | ₹4,876 Cr | ₹363 Cr | |
| ₹790.65 | 56.96 | ₹59,706 Cr | 6.03 | 0.13% | 11.20% | 13.40% | ₹9,506 Cr | ₹1,070 Cr | |
| ₹1,931.50 | 48.36 | ₹39,090 Cr | 7.89 | 0.24% | 20.50% | 15.50% | ₹9,072 Cr | ₹816 Cr | |
| ₹1,402.00 | 67.76 | ₹37,618 Cr | 9.52 | 0.04% | 15.20% | 17.40% | ₹4,683 Cr | ₹552 Cr | |
| Unihealth Hospitals (this company) | ₹543.85 | — | ₹875 Cr | 6.22 | 0.00% | 21.50% | 24.50% | — | — |
| Median 8 companies | ₹858.90 | 61.89 | ₹59,817 Cr | 7.93 | 0.18% | 14.95% | 15.10% | ₹9,072 Cr | ₹906 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 84/100
Category scores
- Quality
- 61
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 22
- Poor
- Cheap vs sector & own history 24% weight
- Growth
- 94
- Strong
- Sales & profit trajectory 9% weight
- Financial Health
- 55
- Average
- Solvency, leverage, coverage 9% weight
- Momentum
- 51
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 33
- Poor
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has delivered good profit growth of 38.6% CAGR over last 5 years
Weaknesses
4- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -4.71%
- Tax rate seems low
- Company has high debtors of 341 days.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Neutral | 7 | 5 | 7 |
| Oscillators | Bullish | 1 | 5 | 3 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bullish
Overall
Neutral
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 44.44
- Neutral
- MACD (12,26,9)
- −18.65
- Bullish
- SMA (50)
- 620.80
- Bearish
- SMA (200)
- 518.09
- Bullish
As of
Growth Rate
From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025.
Revenue
| 5Y | +38.39% |
|---|---|
| 3Y | +44.22% |
| 1Y | +33.33% |
Net profit
| 5Y | +55.87% |
|---|---|
| 3Y | +79.15% |
| 1Y | +70.37% |
Operating cash flow
| 5Y | +8.45% |
|---|---|
| 3Y | +81.71% |
| 1Y | +100.00% |
Operating margin· change in pp
| 5Y | +13.99 pp |
|---|---|
| 3Y | +9.09 pp |
| 1Y | +3.54 pp |
Trailing twelve months: Results are not reported for each of the last eight quarters, so there is no trailing-twelve-month figure.
Revenue by year
| Mar 2020 | ₹22.00 Cr |
|---|---|
| Mar 2021 | ₹26.00 Cr |
| Mar 2022 | ₹37.00 Cr |
| Mar 2023 | ₹44.00 Cr |
| Mar 2024 | ₹49.00 Cr |
| Mar 2025 | ₹99.00 Cr |
| Mar 2026 | ₹132 Cr |
Net profit by year
| Mar 2020 | −₹1.00 Cr |
|---|---|
| Mar 2021 | ₹5.00 Cr |
| Mar 2022 | ₹4.00 Cr |
| Mar 2023 | ₹8.00 Cr |
| Mar 2024 | ₹10.00 Cr |
| Mar 2025 | ₹27.00 Cr |
| Mar 2026 | ₹46.00 Cr |
Half-yearly Results
₹ Cr| Particulars | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Sales | 22 | 27 | 43 | 56 | 67 | 65 |
| Expenses | 15 | 16 | 28 | 34 | 35 | 43 |
| Operating Profit | 7 | 10 | 15 | 21 | 32 | 22 |
| OPM % | 32% | 39% | 35% | 38% | 48% | 34% |
| Other Income | 1 | 1 | 2 | 1 | 3 | 2 |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 2 | 4 | 4 | 6 |
| PBT | 5 | 8 | 13 | 18 | 30 | 17 |
| Tax % | 17% | 28% | 29% | −2% | 4% | −2% |
| Net Profit | 4 | 6 | 9 | 18 | 29 | 17 |
| EPS (₹) | — | — | — | — | 9.75 | 6.83 |
Profit & Loss
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Sales | 22 | 26 | 37 | 44 | 49 | 99 | 132 |
| Expenses | 20 | 20 | 25 | 30 | 31 | 62 | 78 |
| Operating Profit | 2 | 7 | 12 | 14 | 18 | 37 | 54 |
| OPM % | 10% | 25% | 31% | 31% | 36% | 37% | 41% |
| Other Income | 1 | 2 | 1 | 2 | 2 | 3 | 5 |
| Interest | 2 | 1 | 5 | 4 | 3 | 3 | 2 |
| Depreciation | 2 | 2 | 2 | 3 | 2 | 6 | 10 |
| PBT | −1 | 5 | 5 | 9 | 14 | 30 | 46 |
| Tax % | 2% | 9% | 27% | 17% | 24% | 11% | 2% |
| Net Profit | −1 | 5 | 4 | 8 | 10 | 27 | 46 |
| EPS (₹) | — | — | — | — | — | — | 16.45 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity Capital | 1 | 1 | 1 | 1 | 15 | 15 | 16 |
| Reserves | 4 | 9 | 13 | 26 | 70 | 86 | 122 |
| Borrowings | 41 | 39 | 38 | 39 | 15 | 22 | 33 |
| Other Liabilities | 12 | 9 | 12 | 12 | 10 | 62 | 84 |
| Total Liabilities | 58 | 58 | 65 | 78 | 110 | 185 | 254 |
| Fixed Assets | 35 | 35 | 36 | 37 | 36 | 68 | 84 |
| CWIP | 2 | 0 | 0 | 0 | 0 | 5 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 22 | 28 | 41 | 74 | 112 | 160 |
| Total Assets | 58 | 58 | 65 | 78 | 110 | 185 | 254 |
Cash Flow
₹ Cr| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Operating | 1 | 4 | 9 | 1 | 5 | 3 | 6 |
| Investing | −1 | 0 | −4 | −5 | 0 | −5 | −19 |
| Financing | 1 | −3 | −5 | 3 | 22 | −3 | 16 |
| Net Cash Flow | 0 | 1 | 0 | 0 | 27 | −5 | 2 |
| Free Cash Flow | −1 | 4 | 8 | −1 | 2 | −13 | −26 |
| CFO/OP | 32 | 62 | 82 | 22 | 40 | 18 | 16 |
Ratios
| Particulars | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 206 | 198 | 180 | 228 | 251 | 303 | 341 |
| Inventory Days | 50 | 86 | 78 | 98 | 88 | 74 | 100 |
| Days Payable | 382 | 91 | 79 | 137 | 104 | 104 | 138 |
| Cash Conversion Cycle | −125 | 192 | 180 | 188 | 235 | 273 | 304 |
| Working Capital Days | 24 | 137 | 87 | 141 | 203 | 239 | 321 |
| ROCE % | — | 14% | 20% | 22% | 20% | 25% | 24% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Unihealth Hospitals insights
58 extracted metrics across FY20–FY26.
Documents
- Concall · Jun 2026Transcript PPT
- Concall · Nov 2025Transcript PPT
- Concall · May 2025Transcript PPT
- Concall · Nov 2024Transcript PPT Recording
- Concall · May 2024Transcript PPT
- 18 Aug 2025
- 11 Sep 2024
- 31 Jul 2023
- 28 Sep 2026
- 26 Sep 2026
Frequently Asked Questions about Unihealth Hospitals
What does Unihealth Hospitals Ltd do?
Where is Unihealth Hospitals Ltd (UNIHEALTH) listed?
Which sector does Unihealth Hospitals Ltd belong to?
What is the 52-week high and low of Unihealth Hospitals Ltd?
What is the Return on Equity (ROE) of Unihealth Hospitals Ltd?
Company Information
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/UNIHEALTH.md for Unihealth Hospitals Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.